Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Respiratory

Galapagos and Gilead Discontinue Phase 3 ISABELA Program of Ziritaxestat in IPF

Galapagos and Gilead have halted the phase 3 ISABELA program, consisting of two studies evaluating ziritaxestat in patients with idiopathic […]

Galapagos and Gilead Discontinue Phase 3 ISABELA Program of Ziritaxestat in IPF
3 weeks ago
Share

Sleep Apnea is a Risk Factor for Severe COVID-19

A group of Finish and American research study results show that COVID-19 outcome is mediated primarily through respiratory distress. Risk […]

Sleep Apnea is a Risk Factor for Severe COVID-19
4 weeks ago
Share

Amgen, AstraZeneca Report Phase 3 NAVIGATOR Trial of Tezepelumab Meets Primary Endpoint in Patients with Severe Asthma

Amgen and AstraZeneca  announced positive results from NAVIGATOR, a phase 3 trial evaluating tezepelumab versus placebo, both added to standard […]

Amgen, AstraZeneca Report Phase 3 NAVIGATOR Trial of Tezepelumab Meets Primary Endpoint in Patients with Severe Asthma
4 months ago
Share

Pfizer Presents Phase 2 and 3 Data from its 20-valent Pneumococcal Conjugate Vaccine (20vPnC) Candidate

Pfizer presented data from a phase 3 trial of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate in adults 18 years […]

Pfizer Presents Phase 2 and 3 Data from its 20-valent Pneumococcal Conjugate Vaccine (20vPnC) Candidate
4 months ago
Share

Regeneron and Sanofi Announce Dupixent Effective in Phase 3 Pediatric Asthma Trial

Regeneron and Sanofi announced positive results from the phase 3 LIBERTY ASTHMA VOYAGE trial which evaluated Dupixent (dupilumab) in children aged […]

Regeneron and Sanofi Announce Dupixent Effective in Phase 3 Pediatric Asthma Trial
5 months ago
Share

Corbus Pharma’s Lenabasum Fails to Meet Endpoints in Phase 2b Cystic Fibrosis Trial

Corbus Pharmaceuticals announced topline results from its 28-week Phase 2b study (CF-002) of lenabasum in patients with cystic fibrosis (CF). […]

Corbus Pharma’s Lenabasum Fails to Meet Endpoints in Phase 2b Cystic Fibrosis Trial
5 months ago
Share

AstraZeneca’s Tagrisso Effective in Treating Patients with EGFR-mutated Lung Cancer with CNS Metastases

AstraZeneca presented data from its ADAURA Phase III trial showing that Tagrisso (osimertinib) demonstrated clinically meaningful improvement in central nervous […]

AstraZeneca’s Tagrisso Effective in Treating Patients with EGFR-mutated Lung Cancer with CNS Metastases
5 months ago
Share

University of Southampton Spinoff Phase 2 Results Evidence SNG001 Reduces Chance of COVID-19 Severity as Stock Price Erupts

UK-based, publicly traded Synairgen’s stock (LSE:SNG) price exploded recently after positive clinical trial results, while the company has to issue […]

University of Southampton Spinoff Phase 2 Results Evidence SNG001 Reduces Chance of COVID-19 Severity as Stock Price Erupts
8 months ago
Share

UK Gov Approves as U.S. HHS Places Dexamethasone on Treatment Guidelines; Demand Soars & More Data Needed

The government of the United Kingdom (UK) approved dexamethasone, a commonly prescribed steroid treatment, as a COVID-19 therapy thanks to […]

UK Gov Approves as U.S. HHS Places Dexamethasone on Treatment Guidelines; Demand Soars & More Data Needed
8 months ago
Share

Acceleron Presents Topline Results of Phase 2 PULSAR Trial of Sotatercept for Pulmonary Arterial Hypertension

Acceleron Pharma presented positive topline results from the phase 2 PULSAR trial evaluating sotatercept versus placebo for the treatment of […]

Acceleron Presents Topline Results of Phase 2 PULSAR Trial of Sotatercept for Pulmonary Arterial Hypertension
8 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.